Sunitinib associated posterior reversible encephalopathy syndrome in a patient treated for GIST

Acta Neurol Belg. 2020 Aug;120(4):995-997. doi: 10.1007/s13760-020-01367-6. Epub 2020 May 5.

Authors

Nicola Rifino^{1

2}, Vittorio Mantero³, Marco Giuseppe Filizzolo⁴, Paola Basilico³, Chiara Scaccabarozzi³, Jessica Arnoffi⁵, Andrea Salmaggi³

Affiliations

¹ University of Milano-Bicocca, Milan, Italy. [email protected].
² Department of Neurology, Manzoni Hospital, Lecco, Italy. [email protected].
³ Department of Neurology, Manzoni Hospital, Lecco, Italy.
⁴ Department of Neuroradiology, Manzoni Hospital, Lecco, Italy.
⁵ Department of Oncology, Manzoni Hospital, Lecco, Italy.

PMID: 32372399
DOI: 10.1007/s13760-020-01367-6

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Aged
Antineoplastic Agents / adverse effects*
Female
Gastrointestinal Stromal Tumors / drug therapy*
Humans
Posterior Leukoencephalopathy Syndrome / chemically induced*
Protein Kinase Inhibitors / adverse effects*
Sunitinib / adverse effects*

Substances

Antineoplastic Agents
Protein Kinase Inhibitors
Sunitinib